Lunan Pharmaceutical ranks among the top 100 companies in China's pharmaceutical industry in terms of main business revenue in 2025
From July 11 to 12, the 43rd National Pharmaceutical Industry Information Annual Conference and the 2026 Beijing·Changping Life Sciences Forum were held in Changping, Beijing. The conference announced the list of "Top 100 Enterprises in Main Business Revenue of China's Pharmaceutical Industry in 2025". Lunan Pharmaceutical Group ranked 32nd; it was selected as one of the 2026 Outstanding Cases of China's Pharmaceutical R&D Product Line Industrial Enterprises and the 2025 China's Outstanding Cases of Corporate Social Responsibility in the Pharmaceutical Industry.
Zhang Guimin, Secretary of the Party Committee, Chairman and General Manager of Lunan Pharmaceutical Group, was invited to attend the annual meeting and participated in the "High-Quality Development of Traditional Chinese Medicine Industry" Forum, the China Traditional Chinese Medicine Industry Innovation and Development Research Topic Conference and the "AI and Pharmaceutical Innovation - Technology Frontier Paradigm and New Industrial Ecology" forum.
With the theme of "Exploring Life and Creating a Future Together" and with industrial upgrading as the core, this event will create a high-energy platform for policy implementation, achievement transformation, and resource gathering. It will focus on cutting-edge science, industry trends, and policy innovation. Through in-depth exchanges, it will help China's pharmaceutical industry improve its international competitiveness and contribute Chinese wisdom to the development of global health.
Top 100 companies in China's pharmaceutical industry by main business revenue in 2025
1
China National Pharmaceutical Group Co., Ltd.
2
China Resources Pharmaceutical Holdings Co., Ltd.
3
Qilu Pharmaceutical Group Co., Ltd.
4
China Yuanda Group Co., Ltd.
5
Novo Nordisk (China) Pharmaceutical Co., Ltd.
6
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
7
CSPC Pharmaceutical Holdings Group Co., Ltd.
8
Jiangsu Hengrui Pharmaceutical Co., Ltd.
9
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
10
Shanghai Pharmaceutical Group Co., Ltd.
11
Bayer Healthcare GmbH
12
Revised Pharmaceutical Group Co., Ltd.
13
Beijing Novartis Pharmaceutical Co., Ltd.
14
Sichuan Kelun Pharmaceutical Co., Ltd.
15
Shenyang 3SBio Pharmaceutical Co., Ltd.
16
Weigao Group Co., Ltd.
17
Huizhi Pharmaceutical (Dalian) Co., Ltd.
18
Guangzhou Pharmaceutical Group Co., Ltd.
19
AstraZeneca Pharmaceuticals Ltd.
20
Renfu Pharmaceutical Group Co., Ltd.
21
Xinhecheng Holding Group Co., Ltd.
22
Sanofi (China) Investment Co., Ltd.
23
Yangzijiang Pharmaceutical Group Co., Ltd.
24
Livzon Pharmaceutical Group Co., Ltd.
25
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
26
Innovent Biologics (Suzhou) Co., Ltd.
27
Jiangxi Jimin Credible Group Co., Ltd.
28
Changchun High-tech Industry (Group) Co., Ltd.
29
Shandong Buchang Pharmaceutical Co., Ltd.
30
Zhuhai United Laboratories Co., Ltd.
31
China Beijing Tong Ren Tang (Group) Co., Ltd.
32
Lunan Pharmaceutical Group Co., Ltd.
33
Xi'an Janssen Pharmaceutical Co., Ltd.
34
Yunnan Baiyao Group Co., Ltd.
35
Shenzhen Dongguangguang Industrial Development Co., Ltd.
36
Shandong Xinhua Pharmaceutical Co., Ltd.
37
Hangzhou MSD Pharmaceutical Co., Ltd.
38
Zhejiang Huahai Pharmaceutical Co., Ltd.
39
North China Pharmaceutical Group Co., Ltd.
40
Tianjin Pharmaceutical Group Co., Ltd.
41
Jiangsu Yuyue Medical Equipment Co., Ltd.
42
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
43
Prolo Pharmaceutical Co., Ltd.
44
Merck Pharmaceuticals (Jiangsu) Co., Ltd.
45
Fresenius Kabi (China) Investment Co., Ltd.
46
Asymchem Pharmaceutical Group (Tianjin) Co., Ltd.
47
Zhejiang Hisun Pharmaceutical Co., Ltd.
48
Shanghai Roche Pharmaceutical Co., Ltd.
49
Pfizer Pharmaceutical Sciences Co., Ltd.
50
Zhejiang Pharmaceutical Co., Ltd.
51
Xiancere Pharmaceutical Co., Ltd.
52
Harbin Pharmaceutical Group Co., Ltd.
53
Jiangsu Jichuan Holding Group Co., Ltd.
54
Shandong Lukang Pharmaceutical Co., Ltd.
55
Beijing Tide Pharmaceutical Co., Ltd.
56
Zhejiang Conba Pharmaceutical Co., Ltd.
57
Lepu (Beijing) Medical Equipment Co., Ltd.
58
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
59
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
60
Shanghai Chuangnuo Pharmaceutical Group Co., Ltd.
61
Jiangsu Enhua Pharmaceutical Co., Ltd.
62
Tianjin Hongri Pharmaceutical Co., Ltd.
63
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
64
Hualan Bioengineering Co., Ltd.
65
Helion (Suzhou) Pharmaceutical Co., Ltd.
66
Qingfeng Pharmaceutical Group Co., Ltd.
67
Yantai Luye Pharmaceutical Holdings (Group) Co., Ltd.
68
Eli Lilly Suzhou Pharmaceutical Co., Ltd.
69
Hisco Pharmaceutical Group Co., Ltd.
70
Shanghai Boehringer Ingelheim Pharmaceutical Co., Ltd.
71
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.
72
Sichuan Good Doctor Panxi Pharmaceutical Co., Ltd.
73
Chengdu Beite Pharmaceutical Co., Ltd.
74
Shenzhen Xinlitai Pharmaceutical Co., Ltd.
75
Shanghai RAAS Blood Products Co., Ltd.
76
Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
77
Zhejiang Jingxin Pharmaceutical Co., Ltd.
78
Tofflon Technology Group Co., Ltd.
79
Northeast Pharmaceutical Group Co., Ltd.
80
Shijiazhuang Fourth Medicine Co., Ltd.
81
Zhejiang Xianju Pharmaceutical Co., Ltd.
82
Henan Lingrui Pharmaceutical Co., Ltd.
83
Xiamen Tebao Bioengineering Co., Ltd.
84
Sino-American Tianjin SmithKline Pharmaceutical Co., Ltd.
85
Sunway Pharmaceutical Group Co., Ltd.
86
Shandong Qidu Pharmaceutical Co., Ltd.
87
Beida Pharmaceutical Co., Ltd.
88
Chenxin Technology Group Co., Ltd.
89
Neusoft Medical Systems Co., Ltd.
90
Jiangsu Suzhong Health Technology Co., Ltd.
91
Guangzhou Kangchen Pharmaceutical Co., Ltd.
92
Winbond Life & Health Co., Ltd.
93
Zhengzhou Antu Bioengineering Co., Ltd.
94
Jiangsu Kangyuan Pharmaceutical Co., Ltd.
95
Guizhou Jianxing Pharmaceutical Co., Ltd.
96
Eisai (China) Investment Co., Ltd.
97
Ruiyang Pharmaceutical Co., Ltd.
98
Joincare Pharmaceutical Group Co., Ltd.
99
Chutian Technology Co., Ltd.
100
Hunan Jiudian Pharmaceutical Co., Ltd.
Data source: 2025 "China Pharmaceutical Industry Statistical Annual Report"
"Being upright" is not being conservative; systematic thinking is science. On July 11, Zhang Guimin participated in the high-quality development forum of the traditional Chinese medicine industry and explained the logic of traditional Chinese medicine from a philosophical perspective: "Zhongzheng" is the cause, and "peace" is the effect. Taking Qidali® Jingfang Granules as an example, he pointed out that the instructions only say "for colds and colds", but the literature shows that this prescription is actually "warming and treating". "If we can't explain it clearly, we still won't use it next time we encounter an epidemic." He emphasized that the essence of traditional Chinese medicine treatment is to "resolve local uncertainties with overall certainty" and "resolving local uncertainties with overall certainty is the true expression of the holistic view of traditional Chinese medicine."
Entering the "15th Five-Year Plan", biomedicine has been given a new strategic positioning as an emerging pillar industry. As the main force of the industry, the top 100 companies shoulder a higher development mission and demonstration responsibility. Innovation is the main line of development throughout the entire pharmaceutical industry. In the future, Lunan Pharmaceutical will continue to adhere to the guiding principle of "innovation leads and service promotes", continues to increase investment in scientific research and the transformation of results, actively aligns with the national development strategy, and joins hands with industry partners to build a new pattern of coordinated development of the pharmaceutical industry, contributing wisdom and strength to promote the implementation of the "Healthy China" strategy and promote the high-quality development of the national pharmaceutical industry.